Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre Vogel

Showing results (81-90 of 90) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 90 results.
Journal of Enzyme Inhibition and Medicinal Chemistry|June 27, 2022
Structure-based optimization of type III indoleamine 2,3-dioxygenase 1 (IDO1) inhibitorsUte F Röhrig, Somi Reddy Majjigapu, Pierre Vogel, et al.
Journal of Medicinal Chemistry|May 24, 2012
Rational design of 4-aryl-1,2,3-triazoles for indoleamine 2,3-dioxygenase 1 inhibitionUte F Röhrig, Somi Reddy Majjigapu, Aurélien Grosdidier, et al.
European Journal of Medicinal Chemistry|July 19, 2014
Detailed analysis and follow-up studies of a high-throughput screening for indoleamine 2,3-dioxygenase 1 (IDO1) inhibitorsUte F Röhrig, Somi Reddy Majjigapu, Marc Chambon, et al.
Autophagy|February 4, 2014
A critical role of autophagy in antileukemia/lymphoma effects of APO866, an inhibitor of NAD biosynthesisVanessa Ginet, Julien Puyal, Coralie Rummel, et al.
Journal of Medicinal Chemistry|January 9, 2010
Rational design of indoleamine 2,3-dioxygenase inhibitorsUte F Röhrig, Loay Awad, Aurélien Grosdidier, et al.
European Journal of Medicinal Chemistry|March 17, 2018
Induction of cell killing and autophagy by amphiphilic pyrrolidine derivatives on human pancreatic cancer cellsClaudia Bello, Jianfei Bai, Bartosz K Zambron, et al.
Bioorganic & Medicinal Chemistry|March 30, 2010
Novel 2-[(benzylamino)methyl]pyrrolidine-3,4-diol derivatives as alpha-mannosidase inhibitors and with antitumor activities against hematological and solid malignanciesClaudia Bello, Michele Cea, Giovanna Dal Bello, et al.
Molecules (Basel, Switzerland)|February 25, 2023
Anticancer Activities of Novel Nicotinamide Phosphoribosyltransferase Inhibitors in Hematological MalignanciesPaulina Biniecka, Saki Matsumoto, Axel Belotti, et al.
Bioorganic & Medicinal Chemistry|November 15, 2011
Anti-cancer activity of 5-O-alkyl 1,4-imino-1,4-dideoxyribitolsClaudia Bello, Giovanna Dal Bello, Michele Cea, et al.
European Journal of Medicinal Chemistry|June 20, 2022
Identification of new FK866 analogues with potent anticancer activity against pancreatic cancerJian-Fei Bai, Somi Reddy Majjigapu, Bernard Sordat, et al.
Pageof 9

Showing results (81-90 of 90) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 90 results.
Journal of Enzyme Inhibition and Medicinal Chemistry|June 27, 2022
Structure-based optimization of type III indoleamine 2,3-dioxygenase 1 (IDO1) inhibitorsUte F Röhrig, Somi Reddy Majjigapu, Pierre Vogel, et al.
Journal of Medicinal Chemistry|May 24, 2012
Rational design of 4-aryl-1,2,3-triazoles for indoleamine 2,3-dioxygenase 1 inhibitionUte F Röhrig, Somi Reddy Majjigapu, Aurélien Grosdidier, et al.
European Journal of Medicinal Chemistry|July 19, 2014
Detailed analysis and follow-up studies of a high-throughput screening for indoleamine 2,3-dioxygenase 1 (IDO1) inhibitorsUte F Röhrig, Somi Reddy Majjigapu, Marc Chambon, et al.
Autophagy|February 4, 2014
A critical role of autophagy in antileukemia/lymphoma effects of APO866, an inhibitor of NAD biosynthesisVanessa Ginet, Julien Puyal, Coralie Rummel, et al.
Journal of Medicinal Chemistry|January 9, 2010
Rational design of indoleamine 2,3-dioxygenase inhibitorsUte F Röhrig, Loay Awad, Aurélien Grosdidier, et al.
European Journal of Medicinal Chemistry|March 17, 2018
Induction of cell killing and autophagy by amphiphilic pyrrolidine derivatives on human pancreatic cancer cellsClaudia Bello, Jianfei Bai, Bartosz K Zambron, et al.
Bioorganic & Medicinal Chemistry|March 30, 2010
Novel 2-[(benzylamino)methyl]pyrrolidine-3,4-diol derivatives as alpha-mannosidase inhibitors and with antitumor activities against hematological and solid malignanciesClaudia Bello, Michele Cea, Giovanna Dal Bello, et al.
Molecules (Basel, Switzerland)|February 25, 2023
Anticancer Activities of Novel Nicotinamide Phosphoribosyltransferase Inhibitors in Hematological MalignanciesPaulina Biniecka, Saki Matsumoto, Axel Belotti, et al.
Bioorganic & Medicinal Chemistry|November 15, 2011
Anti-cancer activity of 5-O-alkyl 1,4-imino-1,4-dideoxyribitolsClaudia Bello, Giovanna Dal Bello, Michele Cea, et al.
European Journal of Medicinal Chemistry|June 20, 2022
Identification of new FK866 analogues with potent anticancer activity against pancreatic cancerJian-Fei Bai, Somi Reddy Majjigapu, Bernard Sordat, et al.
Pageof 9